Experience

• 

  Stanford university school of medicine

  Feb 2011 - Aug 2020

  Developing therapy and identifying diagnostic biomarkers for Lyme disease. • Testing lead molecules in C3H mice for Lyme disease. Preclinical studies of lead molecules and how the influence the immune system during Lyme disease treatment.• Developing formulations for the lead molecules for the clinical trials in human.• Identified novel diagnostic biomarkers for Lyme disease and developing a multiplex diagnostic kit for Lyme disease and its co-infections Drug development for Lyme disease (Borrelia burgdorferi) and understanding basic mechanisms of drug tolerance of Lyme disease bacteria. • High-throughput screening of drugs for Lyme disease (Borrelia burgdorferi)• In vitro evaluations of hit targets and testing the lead molecules in C3H animal model. Studying Nuclear egress of varicella zoster virus (VZV)

  • Senior scientist

    Feb 2016 - Aug 2020

  • Postdoctoral Scientist

    Feb 2011 - Jan 2016
• 

  Lymetek inc

  Mar 2017 - Aug 2021

  Technical program manager

  - Have led the group in drug discovery, preclinical studies and developing oral formulations for the lead molecules (life cycle of drug development)- Established life cycle management from pre-clinical to clinical development platforms for Diagnostic Biomarkers program- Lead & Manage cross-functional collaborations and timelines between stakeholders, R&D and CRO’s

• 

  Aragen bioscience inc

  Sept 2021 - now

  Sr. project manager